Outcomes of patients receiving additional esophagectomy after endoscopic resection for clinically mucosal, but pathologically submucosal, squamous cell carcinoma of the esophagus

@article{Motoyama2012OutcomesOP,
  title={Outcomes of patients receiving additional esophagectomy after endoscopic resection for clinically mucosal, but pathologically submucosal, squamous cell carcinoma of the esophagus},
  author={Satoru Motoyama and Mario Jin and Tamotsu Matsuhashi and Hiroshi Nanjo and Koichi Ishiyama and Yusuke Sato and Kei Yoshino and Tomohiko Sasaki and Akiyuki Wakita and Hajime Saito and Yoshihiro Minamiya and Hirohide Ohnishi and Jun-ichi Ogawa},
  journal={Surgery Today},
  year={2012},
  volume={43},
  pages={638-642}
}
This study investigated the actual rate or extent of lymph node metastasis or the survival outcomes among patients that underwent esophagectomy with lymph node dissection after ESD for clinical mucosal, but pathological submucosal, esophageal cancer. Seventeen patients that received esophagectomy with two- or three-field lymph node dissection as additional treatment after ESD for clinical mucosal, but pathological submucosal, esophageal cancer between 2006 and 2010 were analyzed. The rate and… CONTINUE READING